Autonomix Medical Inc. has announced a private placement with a single institutional investor, raising approximately $5.0 million through the sale of 4,501,666 shares of common stock (or pre-funded warrants) and unregistered Series C warrants to purchase up to 9,003,332 shares of common stock. The combined offering price is $1.1107 per share and accompanying warrant, with each Series C warrant carrying an exercise price of $0.8607 per share, exercisable immediately and expiring five and a half years from issuance. The securities are being sold under Section 4(a)(2) and/or Regulation D and are not registered under the Securities Act. Autonomix has agreed to file a registration statement to register the resale of the securities. Maxim Group LLC is serving as the sole placement agent for the transaction.